Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi

Journal of Bone and Mineral Research

Volumn 10, Issue 12, 1995, Pages 1913-1929

  McKee, M D ^a   Nancl, A ^a   Khan, S R ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; OSTEOCALCIN; OSTEOPONTIN; SIALOPROTEIN; WHEWELLITE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRYSTALLIZATION; GOLGI COMPLEX; HENLE LOOP; HUMAN; KIDNEY TUBULE CELL; MALE; NEPHROLITHIASIS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RAT; STONE ANALYSIS; ULTRASTRUCTURE;

ANIMAL; BLOOD PROTEINS; CELL ADHESION; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; EPITHELIUM; GENE EXPRESSION REGULATION; GOLD COLLOID; GOLGI APPARATUS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CALCULI; KIDNEY TUBULES; MICROSCOPY, ELECTRON, SCANNING; OSTEOCALCIN; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SIALOGLYCOPROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; UP-REGULATION; URINARY CALCULI;

EID: 0028820604     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.5650101211     Document Type: Article

References (78)

1. Organization of extracellularly mineralized tissues: A comparative study of biological crystal growth
2. Structure and development of calcific urinary stones
3. Adsorption of naturally occurring polymers onto calcium oxalate crystal surfaces
4. Stone matrix as proteins adsorbed on crystal surfaces: A microscopic study
5. Adsorption of molecules of biological interest onto hydroxyapatite
6. Osteopontin‐hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin‐gel
7. Adsorption and modification of calcium salt crystal growth by anionic peptides and spermine
8. Modulation of crystal formation by bone phosphoproteins: Structural specificity of the osteopontin‐mediated inhibition of hydroxyapatite formation
9. Urinary macromolecular crystal growth inhibitors in calcium nephrolithiasis
10. A review of new concepts in renal stone research
11. Role of organic matrix in urinary stone formation: An ultrastructural study of crystal matrix interface of calcium oxalate monohydrate stones
12. Pathogenesis of oxalate urolithiasis: Lessons from experimental studies with rats
13. Calcium oxalate urolithiasis in the rat: Is it a model for human stone disease? A review of recent literature
14. Crystal‐matrix relationships in experimentally induced urinary calcium oxalate monohydrate crystals, an ultrastructural study
15. Identification of urinary stone and sediment crystals by scanning electron microscopy and x‐ray microanalysis
16. Protein A‐gold and protein G‐gold postembedding immunoelectron microscopy
17. Urinary enzymes and calcium oxalate urolithiasis
18. Post‐embedding colloidal‐gold immunocytochemistry of non‐collagenous extracellular matrix proteins in mineralized tissues
19. Architecture of calcium oxalate monohydrate urinary calculi
20. Mechanisms of stone formation—An overview
21. Calcium oxalate nephrolithiasis, a free or fixed particle disease
22. The role of Tamm‐Horsfall glycoprotein and nephrocalcin in calcium oxalate monohydrate crystallization processes
23. Organic matrix of human urinary concretions
24. Mechanisms of genesis and growth of calculi
25. Analysis of renal calculous matrix compared with some other matrix materials and with uromucoid
26. Vitamin K‐dependent gamma‐carboxyglutamic acid formation by kidney microsomes in vitro
27. The presence of protein‐bound gamma‐carboxyglutamic acid in calcium‐containing renal calculi
28. Gamma‐carboxyglutamic acid‐containing protein of rat kidney cortex
29. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine
30. Immunohistochemical localization of nephrocalcin to proximal tubule and thick ascending limb of Henle's loop of human and mouse kidney: Resolution of a conflict
31. Evidence that mouse proximal tubule cells produce nephrocalcin
32. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma‐carboxyglutamic acid
33. Tamm‐Horsfall protein—Uromodulin (1950–1990)
34. Pathophysiology of Tamm‐Horsfall protein
35. Urinary Tamm‐ Horsfall glycoprotein in certain kidney diseases and its content in renal and bladder calculi
36. Tamm‐Horsfall glycoprotein: Inhibitor or promotor of calcium oxalate monohydrate crystallization processes
37. Further studies of matrix substance A
38. The immunological integrity of matrix substance A and its possible detection and quantitation in urine
39. Inclusion of proteins into calcium oxalate crystals precipitated from human urine: A highly selective phenomenon
40. Isolation of acid‐resistant urinary trypsin inhibitors by high performance liquid chromatography and their characterization by N‐terminal amino‐acid sequence determination
41. An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine
42. Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization
43. Uropontin in urinary calcium stone formation
44. Osteopontin: A protein with diverse functions
45. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin
46. Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid‐rich protein superfamily
47. Developmental appearance and ultrastructural immunolocalization of a major 66 kDa phosphoprotein in embryonic and post‐natal chicken bone
48. High‐resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibia
49. 2HS‐glycoprotein) proteins in rat bone
50. Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine
51. Structure and expression of the mRNA encoding urinary stone protein (osteopontin)
52. Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone
53. Osteopontin, a substrate for transglutaminase and factor XIII activity
54. Osteopontin: Its transglutaminase‐catalyzed posttranslational modifications and cross‐linking to fibronectin
55. Localization of transglutaminase‐reactive glutamine residues in bovine osteopontin
56. Evidence for the formation of a complex between osteopontin and osteocalcin
57. Acidic phosphoproteins from bone matrix: A structural rationalization of their role in biomineralization
58. Matrix modulates uptake of calcium oxalate crystals and cell growth of renal epithelial cells
59. Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation
60. Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals
61. Regulation of renal epithelial cell endocytosis of calcium oxalate monohydrate crystals
62. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli
63. Integrins
64. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg‐Gly‐Asp cell binding sequence
65. Mechanism of fibroblast attachment to bone extracellular matrix: Role of a 44 kilodalton bone phosphoprotein
66. 3) in human endothelial cells
67. Osteopontin expression in angiotensin II‐induced tubulointerstitial nephritis
68. 2+‐binding protein of bone matrix
69. Osteocalcin
70. Immunolocalization of osteopontin, osteocalcin, and dentin sialoprotein during dental root formation and early cementogenesis in the rat
71. The identification of the vitamin K‐dependent bone protein osteocalcin as one of the gamma‐carboxyglutamic acid containing protein present in calcified atherosclerotic plaque and mineralized heart valves
72. Identification of osteocalcin mRNA in nonosteoid tissue of rats and humans by reverse transcriptionpolymerase chain reaction
73. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets
74. The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression